Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Friedman

Showing results (11-20 of 321) with videos related to

Pageof 33
Sort By:
The New England Journal of Medicine|December 18, 2015
Cannabinoids in the Treatment of EpilepsyDaniel Friedman, Orrin Devinsky
Journal of the Neurological Sciences|August 22, 2021
Commercially available seizure detection devices: A systematic reviewJennifer Shum, Daniel Friedman
Current Opinion in Neurology|February 25, 2026
Epilepsy advances in 2025Philippe Ryvlin, Daniel Friedman
The Lancet. Neurology|December 18, 2010
Epilepsy: from newly diagnosed to treatment-resistant diseaseJacqueline French, Daniel Friedman
The New England Journal of Medicine|September 10, 2015
Cannabinoids in the Treatment of EpilepsyDaniel Friedman, Orrin Devinsky
Neurology|November 5, 2025
Seizing the Heart: Late-Onset Epilepsy and Cardiovascular Disease in Older AdultsMaria Stefanidou, Daniel Friedman
Epilepsy Research|October 22, 2013
Racial and ethnic differences in epilepsy classification among probands in the Epilepsy Phenome/Genome Project (EPGP)Daniel Friedman, Robyn Fahlstrom,
Neurology|March 1, 2006
Effects of intermittent levetiracetam dosing in a patient with refractory daily seizuresDaniel Friedman, Jacqueline A French
The Lancet. Neurology|August 18, 2012
Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutionsDaniel Friedman, Jacqueline A French
The Lancet. Neurology|June 23, 2023
Appropriate selection of participants for clinical trials in epilepsyJacqueline A French, Daniel Friedman
Pageof 33

Showing results (11-20 of 321) with videos related to

Sort By:
Pageof 33
The New England Journal of Medicine|December 18, 2015
Cannabinoids in the Treatment of EpilepsyDaniel Friedman, Orrin Devinsky
Journal of the Neurological Sciences|August 22, 2021
Commercially available seizure detection devices: A systematic reviewJennifer Shum, Daniel Friedman
Current Opinion in Neurology|February 25, 2026
Epilepsy advances in 2025Philippe Ryvlin, Daniel Friedman
The Lancet. Neurology|December 18, 2010
Epilepsy: from newly diagnosed to treatment-resistant diseaseJacqueline French, Daniel Friedman
The New England Journal of Medicine|September 10, 2015
Cannabinoids in the Treatment of EpilepsyDaniel Friedman, Orrin Devinsky
Neurology|November 5, 2025
Seizing the Heart: Late-Onset Epilepsy and Cardiovascular Disease in Older AdultsMaria Stefanidou, Daniel Friedman
Epilepsy Research|October 22, 2013
Racial and ethnic differences in epilepsy classification among probands in the Epilepsy Phenome/Genome Project (EPGP)Daniel Friedman, Robyn Fahlstrom,
Neurology|March 1, 2006
Effects of intermittent levetiracetam dosing in a patient with refractory daily seizuresDaniel Friedman, Jacqueline A French
The Lancet. Neurology|August 18, 2012
Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutionsDaniel Friedman, Jacqueline A French
The Lancet. Neurology|June 23, 2023
Appropriate selection of participants for clinical trials in epilepsyJacqueline A French, Daniel Friedman
Pageof 33